Advertisement

Experience with Iodine-123 Labeled Antibodies

  • Keith Britton
  • Marie Granowska
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 152)

Abstract

In order to image the distribution of spread of metastases from a primary adenocarcinoma in a patient using radioimmunoscintigraphy, a combination of four factors is required: an antibody specific to the cancer in question; a radiolabel that is optimal for the imaging system and for the kinetics of antibody uptake; a method of labeling the antibody and quality control so that is is suitable for injection into the patient; and, a gamma camera imaging system that enables the distribution of the radiolabeled antibody to be visualized to the best advantage. Although it is evident that the major limitation of the current practice of radioimmunoscintigraphy is the inability to get sufficient numbers of a sufficiently specific antibody on to all the cancer cells that have spread from the primary site, this paper is concerned with the other three requirements: the radiolabel, the labeling method, and the imaging of its distribution, with particular reference to the use of iodine-123.

Keywords

Ovarian Cancer Single Photon Emission Compute Tomography Gamma Camera Detection Figure Potassium Perchlorate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berche, C., Mach, J.P., Lambroso, J.D., Langlais, C., Aubry, F., Buchegger, F., Carrel, S., Rouigier, P., Parmentier, D., and Tubiana, M., 1982, Tomoscintigraphy for detection of gastrointestinal and medullary thyroid cancers. First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Brit. Med. J., 285: 1447.CrossRefGoogle Scholar
  2. Bett, R., Cuninghame, J. G., Hill, J.I.S., Jones, I.G., Taylor, N.K., and Winter, J.A., 1980, Development of a process for routine production of I-125 using the I-127 (p, 5n) 123-Xe→123-I reaction. J. Radioanal. Chem. 56: 237.CrossRefGoogle Scholar
  3. Buraggi, G.L., Turrin, A., Cascinelli, N., Attili, A., Terno, G., Bombardierei, E., Gasparini, M., and Seregni, E., 1985, Immunoscintigraphy with antimelanoma monoclonal antibodies. In: “Immunoscintigraphy” L. Donato & K.E. Britton, Eds. 215–253, Monographs in Nuclear Medicine Volume 1, P. Cox, Ed. Gordon & Breach, London.Google Scholar
  4. Davies, J.O., Davies, E.R., Howe, K., Jackson, P.C., Pitcher, E.M., Sadowski , C.S.. Stirrat, G.M., and Sunderland, C.A., 1985, Radionuclide imaging of ovarian -tumours with I-123 labelled monoclonal antibody. Brit. J. Obstet. Gynaecol. 92:277.CrossRefGoogle Scholar
  5. Epenetos, A.A., Britton, K.E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C.C., Durbin, H., Hawkins, L.A., Malpas, J.S., and Bodmer, W.F., 1982, Targetting of Iodine-123 labelled tumour associated monoclonal antibodies to ovarian, breast and intestinal tumours. Lancet, ii:999.CrossRefGoogle Scholar
  6. Fraker, P.J., and Speek, J.C., 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetra-chloro-3a, 6a-diphenylglycoluril. 80:849.Google Scholar
  7. Goldman, A., Vivian, G., Gordon, I., Pritchard, J., and Kemshead, J.T., 1984, Immunolocalisation of neuroblastoma using radiolabelled monoclonal antibody UJ13A. J. Paediat. 105:252.CrossRefGoogle Scholar
  8. Granowska, M., and Britton, K.E., 1986c, A strategic approach to radio-immunoscintigraphy in ovarian and colorectal cancer. In: “Radioaktive isotope in klinik und forschung” Vol. 17, 377–381. Gasteimer Int. Symp. 1986, R. Hofer and H. Bergman, Eds. Egermann Verlag, Vienna.Google Scholar
  9. Granowska, M., Britton, K.E., Shepherd, J., 1984a, The detection of ovarian cancer using I-123 monoclonal antibody. Radiobiol. Radiother. (Berl) 25: 153.Google Scholar
  10. Granowska, M., Britton, K.E., Shepherd, J.H., Nimmon, C.C., Mather, S., Ward, B., Osborne, R.J., and Slevin, M.L., 1986b, A prospective study of I-123 labelled monoclonal antibody imaging in ovarian cancer. J. Clin. Onc. 4: 730.Google Scholar
  11. Granowska, M., Nimmon, C.C. and Britton, K.E., 1986a, Immunoscintigraphy of ovarian cancer by means of HMFG2 monoclonal antibody. In: “Nuclear medicine in clinical oncology”, 171–174, C. Winkler, Ed. Springer-Verlag, Berlin.CrossRefGoogle Scholar
  12. Granowska, M., Shepherd, J., Britton, K.E., Ward, B., Mather, S., Taylor-Papadimitriou, J., Epenetos, A.A., Carroll, M.J., Nimmon, C.C., Hawkins, L.A., Flatman, W.D., Home, T., and Bodmer, W.F., 1984b, Ovarian cancer: diagnosis using 123-I monoclonal antibody in comparison with surgical findings. Nucl. Med. Commun. 5:485.PubMedCrossRefGoogle Scholar
  13. Home, T., Granowska, M., Dicks-Mireaux, C., Hawkins, L.A., Britton, K.E., Mather, S., Bomanji, J., Kemshead, J.T., Kingston, J., and Malpas, J.S., 1985, Neuroblastoma imaged with I-123 meta iodo benzyl guanidine and with I-123 labelled monoclonal antibody, UJ13A, against neural tissue. Brit. J. Radiol., 58: 476.CrossRefGoogle Scholar
  14. Miller, W.T., and Smith, J.F.G., 1983, Protein iodination using iodogen. Int. J. Appl. Radiat. Isot., 34: 639.CrossRefGoogle Scholar
  15. Ott, R.J., Grey, L.J., Zivanovic, M.A., Flower, M.A., Trott, N.G., Moshakis, V., Coombes, R.C., Neville, A.M., Ormerod, M.G., and Westwood, J.H., 1983, The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine labelled antibodies. Brit. J. Radiol., 56: 101.PubMedCrossRefGoogle Scholar
  16. Pateisky, N., Philipp, K., Skodler, W.D., Czerwenka, K., Hamilton, G., and Burchell, J., 1985, Radioimmunodetection in patients with suspected ovarian cancer. J. Nucl. Med., 26: 1369.PubMedGoogle Scholar
  17. Taylor-Papadimitriou, J., Peterson, J.A., Arklie, J., Burchell, J., Ceriani, R.C., and Bodmer, W.F., 1981, Monoclonal antibodies to epithelium specific components of the human milk fat globulin membrane: production and reaction with cells in culture. Int. J. Cancer, 28: 17.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Keith Britton
    • 1
    • 2
  • Marie Granowska
    • 1
    • 2
  1. 1.Department of Nuclear MedicineSt. Bartholomew’s Hospital and Medical CollegeLondon EC1UK
  2. 2.Imperial Cancer Research Fund UnitSt. Mark’s HospitalLondon EC2UK

Personalised recommendations